By Lucia Mutikani WASHINGTON (Reuters) – U.S. single-family homebuilding increased for a second straight month in March, while permits for future construction surged, offering some glimmers of hope for the depressed housing market ahead of the busy spring selling season. The improvement in the single-family housing market segment, which was reported by the Commerce Department…
By Niket Nishant and Tatiana Bautzer (Reuters) -Goldman Sachs Group Inc is exploring the sale of its Greensky fintech business, the bank’s CEO said on Tuesday, its latest move to scale down its retail ambitions. Greensky, which facilitates home improvement loans to consumers, was acquired by Goldman in September 2021 in a $2.24 billion stock…
By Hannah Confino and Rami Amichay Tel Aviv (Reuters) – Esther Paran navigated her way in a wheelchair through the throngs of Israelis marching through Tel Aviv in protest at government plans to overhaul the country’s judicial system. She was pushed by an aide. She did not bang on drums or yell along with the…
FRANKFURT (Reuters) -The European Central Bank’s (ECB) chief economist on Tuesday backed a further interest rate increase at the ECB’s next meeting but said its size would depend on incoming data, especially a survey of euro zone banks. The ECB is expected to raise rates for a seventh straight meeting on May 4 in a…
By Bhanvi Satija and Manas Mishra (Reuters) – Johnson & Johnson on Tuesday cautioned investors over the lingering impact of inflation-driven costs this year as the healthcare conglomerate issued a conservative full-year profit forecast, and its shares fell more than 2%. J&J also said it expected a steep decline in sales of its blockbuster Crohn’s…
By Huw Jones (Reuters) -The European Union on Tuesday proposed making it harder for states to pour billions of euros of aid into an ailing bank, as Italy did with Monte dei Paschi di Siena six years ago. Proposals from the EU’s executive seek to ensure that banks hold enough resources, in particular debt that…
By Maggie Fick BARCELONA (Reuters) – AstraZeneca is confident that its new version of COVID-19 antibody treatment could protect immunocompromised patients against all known virus variants, its vaccines head said. Laboratory studies show the antibody, called AZD3152, neutralizes all known variants of COVID-19 and AstraZeneca has support from regulators to make the treatment available by…
SHANGHAI (Reuters) -Global automakers, including Toyota and Volkswagen, took the stage at the Shanghai auto show on Tuesday with built-for-China and electric-drive products to compete for a high-stakes comeback in the world’s largest market. But after a year when trends have shifted sharply against the established foreign brands that once dominated in China, executives from…
By Mike Stone and Shivansh Tiwary (Reuters) -U.S. weapons maker Lockheed Martin Corp’s first-quarter results surpassed Wall Street targets on Tuesday despite parts and labor shortages, as simmering geopolitical tensions fueled demand from both U.S. and international customers. Shares of the company rose as much as 3.8% to hit a record high of $508.1 in…
By Natalie Grover and Aby Jose Koilparambil (Reuters) -GSK plans to buy Canada-based drug developer Bellus Health Inc in an all-cash deal for $2 billion as the British drugmaker expands its bet on respiratory therapies. The move to replenish its pipeline comes as GSK investors fret about whether there is enough in the medicine cabinet…
